Home Tags Posts tagged with "overweight adults"

overweight adults

0

US health regulators have approved weight-loss pill Belviq, marking the first new drug treatment in 13 years.

Belviq (lorcaserin hydrochloride), made by Arena Pharmaceutical, can be used by obese or overweight adults with at least one condition.

The drug achieved only modest results in clinical studies, helping people lose on average about 5% of their body weight.

Belviq was rejected in 2010 because of concerns over tumors that developed in animals tested with the drug.

After San Diego-based Arena resubmitted its application with more data, the US Food and Drug Administration (FDA) found little risk of tumors in humans using the drug.

FDA approved weight-loss pill Belviq, marking the first new drug treatment in 13 years

FDA approved weight-loss pill Belviq, marking the first new drug treatment in 13 years

The medication is expected to launch in 2013.

Belviq is designed to block appetite signals in the brain, making patients feel fuller with smaller amounts of food.

Belviq is a serotonin 2C receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition, (e.g., hypertension, dyslipidemia, type 2 diabetes).

The FDA warned that Belviq is not for women who are pregnant or nursing.

With US obesity rates approaching 35% in adults and associated healthcare costs on the rise, many doctors have urged health regulators to give the green light to new weight-loss treatments.

But the agency has set high standards for such medication after safety problems with previously popular weight-loss drugs.

The so-called fen-phen combination had to be pulled from the market in 1997 after being linked to heart valve damage.

In a statement, the FDA said Belviq did not appear to carry the same risks.

However, known side effects of Belviq do include depression, migraine and memory lapses.

The FDA-approved label says the drug should not be used for more than 12 weeks if a 5% weight loss does not occur.

Arena will be required to conduct six studies after marketing the drug, including a study on the drug’s effect on long-term heart health.

 

Researchers at Yale University found that both obesity and liver disease can be triggered by a family of proteins called inflammasomes that alter the balance of microbes in the stomach.

The study, published in the online version of Nature, suggests this altered intestinal environment can be passed on – making obesity an infectious condition.

The finding came to light during a study on stomach bacteria in mice.

The research team found that a deficiency in components of two particular inflammasomes in mice resulted in the development of an altered microbial community associated with increased bacteria.

This determined the severity of non-alcoholic fatty liver disease (NAFLD) and obesity in the mice.

Senior study author Professor Richard Flavell said: “When healthy mice were co-housed with mice that had altered gut microbes, the healthy mice also developed a susceptibility for development of liver disease and obesity.”

Researchers at Yale University found that both obesity and liver disease can be triggered by a family of proteins called inflammasomes that alter the balance of microbes in the stomach

Researchers at Yale University found that both obesity and liver disease can be triggered by a family of proteins called inflammasomes that alter the balance of microbes in the stomach

NAFLD is the result of metabolic syndrome, a collection of disorders that includes obesity and diabetes, and is the leading cause of chronic liver disease in the western world.

It is estimated that up to 30 million people suffer from NAFLD in the United States alone.

Prof. Richard Flavell said the next step will be to extend the research to see if the same effect can be seen in humans.

“We found, in mice, that targeted antibiotic treatment brought the microbial composition back to normal, and thus eased the liver disease. Our hope is that our findings may eventually lead to a treatment for humans.”

In the meantime, overweight adults should use the tried and tested formula of eating a healthy diet and performing half an hour of moderate exercise at least three times a week.